Passionate about Hemp?
SOURCE: THE ICCI With specific reference to Parkinson’s Disease (please read to the end of this blog for the link to the full Review). About: An undeniable global interest in the study of cannabis treatments inspired the creation of the International Cannabis and Cannabinoid Institute (ICCI), the first Center of Excellence in this field located in the heart of Europe
Read more
Cannabis Hemp Conference and Expo Published on 22 Jun 2017 Dear Dr. Ethan, Thank you for your prompt responses to our communications and for your highly valued knowledge. Kind regards, Nicholas Hill The Hemp Club SOURCE, YOUTUBE: https://www.youtube.com/watch?v=xtphZejvGhk
Read more
A fantastic podcast on the topic
Read more
SOURCE: https://www.newcannabisventures.com/dea-green-lights-epidiolex-as-first-cannabis- September 27, 2018 at 9:22 am Breaking News by Alan Brochstein, CFA The DEA has given Epidiolex, the CBD-based pharmaceutical derived from cannabis that was approved by the FDA for the treatment of rare forms of epilepsy in June, Schedule V status according to the Office of the Federal Register. The developer of the pharmaceutical, GW Pharma (NASDAQ:
Read more
A short quote from the .pdf (a link to the detailed analysis is at the end of this post). ” Parkinson’s disease This disease, whose symptoms especially include a decrease in the number of dopaminergic neurons in the basal ganglia (“BG”), is, due to its high prevalence (especially among older patients) and simultaneous existence of endocannabinoid receptors in the BG
Read more
DR. DUSTIN SULAK March 12, 2018 (Nastasic/istock) Cannabidiol (CBD) is an exciting focus of medical research, popular media, and legislation related to cannabis. Its presence is becoming ubiquitous on the shelves of health food stores and search engine results for numerous medical conditions, but don’t believe everything you hear. While CBD is an incredibly safe and therapeutic component of cannabis, there
Read more